Matches in SemOpenAlex for { <https://semopenalex.org/work/W1573574201> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W1573574201 abstract "The purpose of this research was to enhance the targeted radiotherapy of two metastatic malignant diseases: neuroblastoma and prostatic carcinoma.By virtue of its high affinity for the norepinephrine transporter (NET), [131I]meta-iodobenzylguanidine ([131I]MIBG) has been used for the therapy of tumours of neuroectodermal origin for more than 25 years. Although not yet universally adopted, [131I]MIBG targeted radiotherapy remains a highly promising means of management of neuroblastoma. MIP-1095, a glutamate-urea-lysine dipeptide has high affinity for prostate-specific membrane antigen (PSMA) and has recently demonstrated exquisite specificity for PSMA-expressing, metastatic prostatic carcinoma. Preliminary imaging studies in patients, using [123I]MIP-1095, revealed tumour-selective binding and prolonged retention only in malignant sites. This indicates the therapeutic potential of this agent when labeled with Iodine-131.Our aim is to make the most effective use of [131I]MIBG and [131I]MIP-1095 for the treatment of neuroblastoma and prostatic carcinoma by combining the [131I]-labelled radiopharmaceutical with radiosensitiser drugs. The thiol-containing molecule disulfiram was selected for combination with targeted radiotherapy because of its reported inhibition of the 26S proteasome and NF-kB activity, its ability to chelate copper and its pro-oxidative effects. The copper-dependence of the cytotoxicity and radiosensitising activity of disulfiram was established in neuroblastoma cell models. Radiation dose enhancement values at the 50% toxicity level were 4.24 and 2.00 in SK-N-BE(2c) and UVW/NAT cells, respectively. The radiosensitising mechanism of disulfiram-copper was shown to involve the inhibition of cell cycle arrest in G2. The enhancement of the cytotoxicity of [131I]mIBG and of [131I]MIP-1095 by disulfiram-copper was demonstrated by delay of the growth of multicellular tumour spheroids.Finally, the screening of the enhancing effect of chemotherapeutic agents on the spheroid growth delay induced by [131I]MIP-1095 indicated that combinations with topotecan, nutlin-3, bortezomib or olaparib have good prospects for therapy of metastatic prostate carcinoma. In conclusion, it is expected that DSF:Cu will enhance the outcome of patients undergoing targeted radiotherapy due to its radiosensitising properties." @default.
- W1573574201 created "2016-06-24" @default.
- W1573574201 creator A5023231307 @default.
- W1573574201 date "2013-01-01" @default.
- W1573574201 modified "2023-09-22" @default.
- W1573574201 title "Copper-dependent enhancement of targeted radiotherapy by combination with the radiosensitiser disulfiram" @default.
- W1573574201 hasPublicationYear "2013" @default.
- W1573574201 type Work @default.
- W1573574201 sameAs 1573574201 @default.
- W1573574201 citedByCount "0" @default.
- W1573574201 crossrefType "dissertation" @default.
- W1573574201 hasAuthorship W1573574201A5023231307 @default.
- W1573574201 hasConcept C109316439 @default.
- W1573574201 hasConcept C126322002 @default.
- W1573574201 hasConcept C185592680 @default.
- W1573574201 hasConcept C202751555 @default.
- W1573574201 hasConcept C2776715637 @default.
- W1573574201 hasConcept C2778523461 @default.
- W1573574201 hasConcept C502942594 @default.
- W1573574201 hasConcept C509974204 @default.
- W1573574201 hasConcept C54355233 @default.
- W1573574201 hasConcept C55493867 @default.
- W1573574201 hasConcept C71924100 @default.
- W1573574201 hasConcept C81885089 @default.
- W1573574201 hasConcept C86803240 @default.
- W1573574201 hasConcept C98274493 @default.
- W1573574201 hasConceptScore W1573574201C109316439 @default.
- W1573574201 hasConceptScore W1573574201C126322002 @default.
- W1573574201 hasConceptScore W1573574201C185592680 @default.
- W1573574201 hasConceptScore W1573574201C202751555 @default.
- W1573574201 hasConceptScore W1573574201C2776715637 @default.
- W1573574201 hasConceptScore W1573574201C2778523461 @default.
- W1573574201 hasConceptScore W1573574201C502942594 @default.
- W1573574201 hasConceptScore W1573574201C509974204 @default.
- W1573574201 hasConceptScore W1573574201C54355233 @default.
- W1573574201 hasConceptScore W1573574201C55493867 @default.
- W1573574201 hasConceptScore W1573574201C71924100 @default.
- W1573574201 hasConceptScore W1573574201C81885089 @default.
- W1573574201 hasConceptScore W1573574201C86803240 @default.
- W1573574201 hasConceptScore W1573574201C98274493 @default.
- W1573574201 hasLocation W15735742011 @default.
- W1573574201 hasOpenAccess W1573574201 @default.
- W1573574201 hasPrimaryLocation W15735742011 @default.
- W1573574201 hasRelatedWork W1489914716 @default.
- W1573574201 hasRelatedWork W1979909272 @default.
- W1573574201 hasRelatedWork W1992134233 @default.
- W1573574201 hasRelatedWork W2023067487 @default.
- W1573574201 hasRelatedWork W2043683467 @default.
- W1573574201 hasRelatedWork W2063591240 @default.
- W1573574201 hasRelatedWork W2083170477 @default.
- W1573574201 hasRelatedWork W2108922094 @default.
- W1573574201 hasRelatedWork W2114830715 @default.
- W1573574201 hasRelatedWork W2408466918 @default.
- W1573574201 hasRelatedWork W2519838369 @default.
- W1573574201 hasRelatedWork W2561363142 @default.
- W1573574201 hasRelatedWork W2582186816 @default.
- W1573574201 hasRelatedWork W2751834927 @default.
- W1573574201 hasRelatedWork W2790416057 @default.
- W1573574201 hasRelatedWork W287605918 @default.
- W1573574201 hasRelatedWork W2924558692 @default.
- W1573574201 hasRelatedWork W3176513577 @default.
- W1573574201 hasRelatedWork W99503824 @default.
- W1573574201 hasRelatedWork W2870701305 @default.
- W1573574201 isParatext "false" @default.
- W1573574201 isRetracted "false" @default.
- W1573574201 magId "1573574201" @default.
- W1573574201 workType "dissertation" @default.